Showing results (341-350 of 12,169) with videos related to
Sort By:
Pageof 1,217
Journal of Cardiovascular Pharmacology|September 28, 1999
Efficacy and safety of spirapril in mild-to-moderate hypertensionK Hayduk, H KraulJournal of Cardiovascular Pharmacology|June 3, 2000
Serotonin reuptake inhibitor fluoxetine decreases arteriolar myogenic tone by reducing smooth muscle [Ca2+]iZ Ungvari, P Pacher, A KollerJournal of Cardiovascular Pharmacology|June 3, 2000
Vascular and endothelial actions of inhibitors of substance P amidationG A Abou-Mohamed, J Huang, C D Oldham, et al.Journal of Cardiovascular Pharmacology|June 3, 2000
Effects of short- and long-term exercise on urinary cGMP excretion in healthy subjects and in patients with coronary artery diseaseA B Alfieri, L G Rodriguez-Plaza, L X CubedduJournal of Cardiovascular Pharmacology|June 3, 2000
Acute effects of a single low oral dose of pimobendan on left ventricular systolic and diastolic function in patients with congestive heart failureR Ishiki, T Ishihara, H Izawa, et al.Journal of Cardiovascular Pharmacology|June 3, 2000
Comparative effects of angiotensin II AT-1-type receptor antagonists in vitro on human platelet activationM Montón, A Jiménez, A Núñez, et al.Journal of Cardiovascular Pharmacology|June 3, 2000
Effects of intravenous nicorandil on coronary circulation in humans: plasma concentration and action mechanismI Nakae, T Matsumoto, H Horie, et al.Journal of Cardiovascular Pharmacology|June 3, 2000
Differential effects of imidapril and candesartan cilexetil on plasminogen activator inhibitor-1 expression induced by prolonged inhibition of nitric oxide synthesis in rat heartsM Katoh, K Egashira, T Mitsui, et al.Journal of Cardiovascular Pharmacology|June 3, 2000
Additive hypotensive effect of angiotensin-converting enzyme inhibition and angiotensin-receptor antagonism in essential hypertensionG S Stergiou, I I Skeva, N M Baibas, et al.Journal of Cardiovascular Pharmacology|June 3, 2000
Inhibitors of ischemic preconditioning do not attenuate Na+/H+ exchange inhibitor mediated cardioprotectionR J Gumina, N Beier, P Schelling, et al.Pageof 1,217